1. Home
  2. PTIX vs XXII Comparison

PTIX vs XXII Comparison

Compare PTIX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • XXII
  • Stock Information
  • Founded
  • PTIX 1994
  • XXII 1998
  • Country
  • PTIX United States
  • XXII United States
  • Employees
  • PTIX N/A
  • XXII N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • XXII Medicinal Chemicals and Botanical Products
  • Sector
  • PTIX Health Care
  • XXII Health Care
  • Exchange
  • PTIX Nasdaq
  • XXII Nasdaq
  • Market Cap
  • PTIX 1.9M
  • XXII 2.1M
  • IPO Year
  • PTIX 2016
  • XXII N/A
  • Fundamental
  • Price
  • PTIX $3.03
  • XXII $1.08
  • Analyst Decision
  • PTIX
  • XXII
  • Analyst Count
  • PTIX 0
  • XXII 0
  • Target Price
  • PTIX N/A
  • XXII N/A
  • AVG Volume (30 Days)
  • PTIX 259.3K
  • XXII 603.9K
  • Earning Date
  • PTIX 05-27-2025
  • XXII 05-13-2025
  • Dividend Yield
  • PTIX N/A
  • XXII N/A
  • EPS Growth
  • PTIX N/A
  • XXII N/A
  • EPS
  • PTIX N/A
  • XXII N/A
  • Revenue
  • PTIX N/A
  • XXII $23,869,000.00
  • Revenue This Year
  • PTIX N/A
  • XXII $19.23
  • Revenue Next Year
  • PTIX N/A
  • XXII $81.05
  • P/E Ratio
  • PTIX N/A
  • XXII N/A
  • Revenue Growth
  • PTIX N/A
  • XXII N/A
  • 52 Week Low
  • PTIX $2.51
  • XXII $0.70
  • 52 Week High
  • PTIX $26.18
  • XXII $226.80
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 45.51
  • XXII 47.15
  • Support Level
  • PTIX $2.82
  • XXII $1.06
  • Resistance Level
  • PTIX $3.68
  • XXII $1.26
  • Average True Range (ATR)
  • PTIX 0.54
  • XXII 0.17
  • MACD
  • PTIX 0.03
  • XXII 0.04
  • Stochastic Oscillator
  • PTIX 37.16
  • XXII 49.25

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: